IP Library Granted Patent US 9,636,175
Granted Patent B2
US 9,636,175 · App. 14/074,927 · Granted May 2, 2017

Apparatus for transcutaneously treating tissue

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,636,175
App. No.
14/074,927
Granted
May 2, 2017
Kind
B2
Abstract

An apparatus for transcutaneously treating tissue beneath a skin surface using radiofrequency energy. The apparatus includes an electrode assembly supported by a handpiece. The electrode assembly includes an electrode configured to transfer the radiofrequency energy through the skin surface to the tissue. A force sensor, which is located in the handpiece, is configured to detect an amount of force applied by the electrode against the skin surface.

Claims (24)

1. An apparatus for transcutaneously treating tissue beneath a skin surface using radiofrequency energy, the apparatus comprising:

a handpiece;

an electrode assembly supported by the handpiece, the electrode assembly including flex circuit with a dielectric portion and a conductive portion comprising an electrode configured to capacitively deliver the radiofrequency energy to the tissue; and

a force sensor coupled to the flex circuit,

wherein the electrode assembly is configured to reduce at least one of an edge effect, an electrode edge effect, or an electrode current density gradient.

2. The apparatus of claim 1 further comprising:

a thermocouple, a thermistor, an infrared photo-emitter, a thermally sensitive diode, an optical sensor, a current sensor, a voltage sensor, an impedance sensor, or a flow sensor coupled to the electrode assembly.

3. The apparatus of claim 1 further comprising:

a cooling media delivery member coupled to the electrode assembly, the cooling media delivery member configured to deliver a cooling media to the electrode assembly.

4. The apparatus of claim 3 further comprising:

a non-volatile memory coupled to the electrode assembly, the non-volatile memory configured to store at least one of a duty cycle for controlling the cooling media delivery member, a number of times the electrode assembly has been moved relative to the skin surface, or a number of areas treated by the electrode assembly.

5. The apparatus of claim 4 wherein the non-volatile memory is mechanically coupled to the electrode assembly.

6. The apparatus of claim 1 further comprising:

a non-volatile memory coupled to the electrode assembly.

7. The apparatus of claim 6 wherein the non-volatile memory is configured to store at least one of a number of times the electrode assembly has been moved relative to the skin surface, or a number of areas treated by the electrode assembly.

8. The apparatus of claim 6 wherein the non-volatile memory is mechanically coupled with the electrode assembly.

9. The apparatus of claim 1 wherein the handpiece includes a sensor and a first microprocessor configured to acquire and analyze data received from the sensor.

10. The apparatus of claim 9 wherein the first microprocessor is configured to control a component on the handpiece.

11. The apparatus of claim 9 further comprising:

a radiofrequency generator coupled with the electrode assembly, the radiofrequency generator including a second microprocessor configured to receive the data from the first microprocessor.

12. The apparatus of claim 1 wherein the electrode assembly includes a sensor, the handpiece includes a first microprocessor configured to acquire and analyze data received from the sensor.

13. The apparatus of claim 12 wherein the first microprocessor is configured to control a component on the handpiece.

14. The apparatus of claim 12 further comprising:

a radiofrequency generator coupled with the electrode assembly, the radiofrequency generator including a second microprocessor configured to receive the data from the first microprocessor.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
Reel/Frame 073637/0126 →
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
SECURITY INTEREST Recorded Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
SECURITY INTEREST Recorded Jul 19, 2017
From: SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043041/0921 →
SECURITY INTEREST Recorded Jul 18, 2016
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSH & LOMB PHARMA HOLDINGS CORP.; DENDREON PHARMACEUTICALS, INC.; DOW PHARMACEUTICAL SCIENCES, INC.; MEDICIS PHARMACEUTICAL CORPORATION; OBAGI MEDICAL PRODUCTS, INC.; OMP, INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; SOLTA MEDICAL, INC.; VALEANT CANADA LP, BY ITS GENERAL PARTNER VALEANT CANADA GP LIMITED; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT HOLDINGS IRELAND (AS SUCCESSOR TO VALEANT INTERNATIONAL BERMUDA); VALEANT PHARMACEUTICALS NORTH AMERICA LLC; VALEANT PHARMACEUTICALS IRELAND
To: BARCLAYS BANK PLC
Reel/Frame 039380/0385 →